🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to investigate the safety, tolerability, and...
Status
Active Not Recruiting
Location
Research Site
Start Date
2018-05-08
Trial ID
NCT03381274
Treatments Being Tested
Osimertinib is an epidermal growth factor receptor tyrosine kinase inhibito...
Status
Unknown
Location
CHU d'ANGERS
Start Date
2019-04-09
Trial ID
NCT03865511
Treatments Being Tested
This is a Phase I/II, Open Label Study of WSD0922-FU in Combination with Os...
Status
Recruiting
Location
Shanghai East Hospital
Start Date
2025-10-17
Trial ID
NCT07206498
Treatments Being Tested
This study was to assess the antitumor activity, safety, tolerability, and ...
Status
Completed
Location
Yuma Regional Medical Center
Start Date
2019-09-19
Trial ID
NCT03940703
Treatments Being Tested
Non-interventional, multi-country, multi-centre cohort study based on exist...
Status
Completed
Location
Royal Marsden Hospital
Start Date
2019-12-17
Trial ID
NCT04179890
The aim of this study is to evaluate clinical outcomes of 2nd line therapy ...
Status
Terminated
Location
Research Site
Start Date
2015-06
Trial ID
NCT02405247
Treatments Being Tested
The purpose of this study is to assess the anti-tumor efficacy, safety, tol...
Status
Terminated
Location
Scottsdale Healthcare Hospitals
Start Date
2018-03-22
Trial ID
NCT03418532
Treatments Being Tested
This is a non-interventional, multi-country, multi-centre cohort study base...
Status
Completed
Location
Otto-Wagner Hospital
Start Date
2017-12-28
Trial ID
NCT03370770
Treatments Being Tested